Hormone replacement therapy in a patient with Shereshevsky—Turner syndrome and a history of congenital thrombophilia and estrogen-associated thrombosis

Safiullina S.I.

Kazan State Medical University, Ministry of Health of Russia, Kazan, Russia

Vuimo T.A.

Higher School of Molecular and Experimental Medicine, Dmitry Rogachev Federal Research-and-Clinical Center for Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia, Moscow, Russia

Budykina T.S.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Ilizarova N.A.

Kazan State Medical University, Ministry of Health of Russia, Kazan, Russia

Hormone replacement therapy in a patient with Shereshevsky—Turner syndrome and a history of congenital thrombophilia and estrogen-associated thrombosis

Authors:

Safiullina S.I., Vuimo T.A., Budykina T.S., Ilizarova N.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2018;18(4): 84‑87

DOI: 10.17116/rosakush201818484

Downloaded: 66

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Safiullina SI, Vuimo TA, Budykina TS, Ilizarova NA. Hormone replacement therapy in a patient with Shereshevsky—Turner syndrome and a history of congenital thrombophilia and estrogen-associated thrombosis. Russian Bulletin of Obstetrician-Gynecologist. 2018;18(4):84‑87. (In Russ.)
https://doi.org/10.17116/rosakush201818484

Подписка 2025-2 (Russian Bulletin of Obstetrician-Gynecologist)

Close metadata

The paper describes a clinical case of personalized selection of hormone replacement therapy in combination with thromboprophylaxis in a female patient with Shereshevsky—Turner syndrome and a history of congenital thrombophilia and estrogen-associated thrombosis. Oral anticoagulants were used as thromboprophylaxis agents. The combined therapy was monitored and controlled using a global thrombodynamics test. The prescribed therapy made it possible to choose the optimal regimen of hormone replacement therapy and thromboprophylaxis and to improve the patient’s health.

Keywords:

Shereshevsky—Turner syndrome with congenital thrombophilia

hormone replacement therapy

thrombosis prevention

direct oral anticoagulants

global thrombodynamics test

Authors:

Safiullina S.I.

Kazan State Medical University, Ministry of Health of Russia, Kazan, Russia

Vuimo T.A.

Budykina T.S.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Ilizarova N.A.

Kazan State Medical University, Ministry of Health of Russia, Kazan, Russia

List of references:

Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause Fertility and Sterility. 2016;7:1588-1599. https://doi.org/10.1016/j.fertnstert.2016.09.046
Primary ovarian insufficiency. A Clinical guide to early menopause. Ed. Santoro NF, Cooper A.R. Springer International Publishing. January. 2016;207. https://doi.org/10.1007/978-3-319-22491-6_12
Tsimaris P, Vrachnis N, Iliodromiti Z, Deligeoroglou E. Long-term followup of adolescent and young adult females with hypergonadotropic hypogonadism. Int J Endocrinol. 2012;2012:680569. https://doi.org/10.1155/2012/862892
Gordon CM, Kanaoka T, Nelson LM. Update on primary ovarian insufficiency in adolescents. Curr Opin Pediatr. 2015;4:511-519. https://doi.org/10.1097/MOP.0000000000000236
Kanj RV, Ofei-Tenkorang NA, Altaye M, Gordon CM. Evaluation and management of primary ovarian insufficiency in adolescents and young adults. J Pediatr Adol Gynecol. 2018;1:13-18. https://doi.org/10.1016/j.jpag.2017.07.005
Menopause hormone therapy and preservation of woman’s health at a nature age. Clinical recommendations. (Report of treatment). Pis’mo Ministerstva zdravookhraneniya RF 02.10.2015. № 15–4/10/2–5804. (In Russ.)
Baber RJ, Panay N, Fenton A. and the IMS Writing Group NS 2016 IMS. Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19:2:109-150. https://doi.org/10.3109/13697137.2015.1129166
Webber L, Anderson RA, Davies M, Janse F, Vermeulen N. HRT for women with premature ovarian insufficiency: a comprehensive review. Human Reprod Open. 2017;1:11. https://doi.org/10.1093/hropen/hox007REVIEW
Canonico M. Hormone therapy and hemostasis among postmenopausal women: a review. Menopause: J North Am Menopause Society. 2014;7:753-762. https://doi.org/10.1097/gme.0000000000000296
Gromova OA, Torshin IYu, Tetruashvili NK, Limanova OA, Serov VN. Molecular-pharmacological mechanisms of stimulation of hypercoagulation with oral and transdermal estrogens. Ginekologiya. 2014;2:22-28. (In Russ.)
Van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Human Reprod Update. 2012;1:473. https://doi.org/10.1093/humupd/dms017
Application of the thrombodynamics test to assess the status of the hemostatic system: educational guide]. Ed. Shulutko AM. Moscow. 2015;85. (In Russ.)
Brinkman HJM. Global assays and the management of oral anticoagulation. Thrombosis J. 2015;13:9. https://doi.org/10.1186/s12959-015-0037-1
Panteleev MA, Hemker HC. Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects. Thrombosis J. 2015;1:1-4. https://doi.org/10.1186/s12959-014-0032-y
Lipets EN, Ataullakhanov FI, Panteleev MA. Integral laboratory tests of hemostasis in the diagnosis of hypercoagulation and assessment of the risk of thrombosis. Onkogematologiya. 2015;3:73-91. (In Russ.) https://doi.org/10.17650/1818-8346-2015-10-3-73-77

Close metadata